Higher estimated plasma volume status may be associated with an inferior survival in patients with pulmonary embolism
2022; Wiley; Volume: 45; Issue: 2 Linguagem: Inglês
10.1111/ijlh.13982
ISSN1751-553X
AutoresIvan Krečak, Karla Nižetić, Monika Čeko, Marko Skelin, Marko Lucijanić,
Tópico(s)Inflammatory Biomarkers in Disease Prognosis
ResumoInternational Journal of Laboratory HematologyVolume 45, Issue 2 p. e32-e35 LETTER TO THE EDITOR Higher estimated plasma volume status may be associated with an inferior survival in patients with pulmonary embolism Ivan Krečak, Corresponding Author Ivan Krečak [email protected] orcid.org/0000-0002-8642-305X Department of Internal Medicine, General Hospital of Šibenik-Knin County, Šibenik, Croatia School of Medicine, University of Rijeka, Rijeka, Croatia Correspondence Ivan Krečak, Department of Internal Medicine, General Hospital of Šibenik-Knin County, Stjepana Radića 83 22000 Šibenik, Croatia. Email: [email protected]Search for more papers by this authorKarla Nižetić, Karla Nižetić Department of Internal Medicine, General Hospital of Šibenik-Knin County, Šibenik, CroatiaSearch for more papers by this authorMonika Čeko, Monika Čeko Department of Internal Medicine, General Hospital of Šibenik-Knin County, Šibenik, CroatiaSearch for more papers by this authorMarko Skelin, Marko Skelin School of Medicine, University of Rijeka, Rijeka, Croatia Pharmacy Department, General Hospital of Šibenik-Knin County, Šibenik, CroatiaSearch for more papers by this authorMarko Lucijanić, Marko Lucijanić Division of Hematology, University Hospital Dubrava, Zagreb, Croatia School of Medicine, University of Zagreb, Zagreb, CroatiaSearch for more papers by this author Ivan Krečak, Corresponding Author Ivan Krečak [email protected] orcid.org/0000-0002-8642-305X Department of Internal Medicine, General Hospital of Šibenik-Knin County, Šibenik, Croatia School of Medicine, University of Rijeka, Rijeka, Croatia Correspondence Ivan Krečak, Department of Internal Medicine, General Hospital of Šibenik-Knin County, Stjepana Radića 83 22000 Šibenik, Croatia. Email: [email protected]Search for more papers by this authorKarla Nižetić, Karla Nižetić Department of Internal Medicine, General Hospital of Šibenik-Knin County, Šibenik, CroatiaSearch for more papers by this authorMonika Čeko, Monika Čeko Department of Internal Medicine, General Hospital of Šibenik-Knin County, Šibenik, CroatiaSearch for more papers by this authorMarko Skelin, Marko Skelin School of Medicine, University of Rijeka, Rijeka, Croatia Pharmacy Department, General Hospital of Šibenik-Knin County, Šibenik, CroatiaSearch for more papers by this authorMarko Lucijanić, Marko Lucijanić Division of Hematology, University Hospital Dubrava, Zagreb, Croatia School of Medicine, University of Zagreb, Zagreb, CroatiaSearch for more papers by this author First published: 12 October 2022 https://doi.org/10.1111/ijlh.13982Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat Volume45, Issue2April 2023Pages e32-e35 RelatedInformation
Referência(s)